Frequency and preventability of adverse drug events in the outpatient setting.
Wasserman RL, Edrees HH, Amato MG, et al. Frequency and preventability of adverse drug events in the outpatient setting. BMJ Qual Saf. 2024;Epub Jul 9. doi:10.1136/bmjqs-2024-017098.
Adverse drug events (ADEs) remain a persistent patient safety challenge. This retrospective analysis of 3,323 patients treated in outpatient settings in 2018 found that 5% experienced an ADE. Most ADEs involved cardiovascular, central nervous system, or anti-infective medications. The researchers concluded that 22% of these ADEs were likely preventable through strategies such as improved education, training, communication, and monitoring or the use of clinical decision support tools or alerts.